Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by KidCashon Jan 05, 2021 1:27pm
66 Views
Post# 32224760

RE:Kushmans cut for P&D

RE:Kushmans cut for P&DI think you need to put the crack pipe down. .15 lol? They are already in phase 2 with Nano. That started in November/December (stated in NR). That process can take 6 mos to get to finished product but they are fasttracking it through as partners and TB already has a relationship with HC and the FDA so I would be looking towards the end of this month for the application and approvals based on the urgency. Products should ship in Feb or March at the latest. Nano is ready. Assay optimization is close to complete with more than HC and FDA requirements are for approval. Cassettes, readers and sample prep is next before final product freeze for manufacture. 

This is where the 300 tests based on the prototype come into play which should be soon if it already hasn't been done and they are putting final touches/tweeks before moving to prod. The next NR should be around that within the next couple of weeks. Ford and Trudope won't sit on this once they see it works.

Do some DD and post stuff that actually makes sense. Your guessing doesn't help. .15 give you f*ckin head a shake.


optex1972 wrote:

Honestly wonder what it is? He plays game well he went onto Twitter ignore as this was down to .06 now re compensated is spreading a lot of fluff to support the price. Seems his pump yesterday give us a kick but what's the real deal? In order to even sell and make a single dollar you need to have a device, then you have to submit your processes, analytical proven results, then wait in que through health Canada, fda, eu approvals. Facts are this at best of all stars even align is months away and with a changing strain ahead of us summer imo at best. That's to actually make revenue so the cash on hand, burn rate becomes critical. 


for now trade the pumps and enter when below .15 each cycle and can make some money but don't be unrealistic to timelines. We all seen by Sona how hard it is. 



<< Previous
Bullboard Posts
Next >>